ActX Bridges the Gap Between Better Patient Care and Current Physician Genetic Knowledge

Share Article

ActX introduces GenoACT, a Genetic Clinical Decision Support Service. The GenoACT service was developed and is continually updated by a talented scientific team that includes geneticists, PharmD’s, genetic counselors, and physicians aided by machine learning (AI).

ActX introduces GenoACT(sm), a Genetic Clinical Decision Support Service. The GenoACT service was developed and is continually updated by a talented scientific team that includes geneticists, PharmD’s, genetic counselors, and physicians aided by machine learning (AI). The integrated service provides:
1. Information on the medical impact of a patient’s genetic variants
2. Educational information for clinicians, with references
3. Actionable clinical recommendations to address the variants    

GenoACT covers the key clinically relevant areas of pharmacogenomics, hereditary risk and carrier status. Integrated into the Electronic Health Record (EHR), GenoACT blends seamlessly into normal workflow. By providing actionable information only as it is needed, GenoACT prevents the common problem of physician information overload. GenoACT actively checks prescriptions as they are written and identifies ineffective medications, potential adverse reactions, and dosing considerations. For actionable hereditary risk and carrier status, physicians are alerted in their normal clinical inbox initially and over time as new research uncovers potentially serious risks for all patient variants on file.

Most major EHR vendors (10 in total) have chosen to integrate the ActX Service within their EHRs. They have identified the value to health systems and physician practices of making precision medicine a core part of physician workflow, using the functionality of GenoACT.

Dr. Andrew Ury, founder of ActX explained: “As a working physician I recognized early in my career how difficult it was to stay on top of all the latest research. As Precision Medicine has evolved the clinical research on the use of a patient’s genetic variants has exploded and the knowledge gap has become a major stumbling block. By incorporating GenoACT into a clinician’s normal daily work flow, we have finally found a way to bridge this gap, through the use of up to date integrated, actionable, clinical decision support.”

About ActX:
Founded in 2012, ActX helps physicians make better decisions about medical treatment, using a patient’s genetic information to guide therapy. Integrated into a physician’s normal software tools (the electronic medical record) and workflow, ActX analyzes the patient’s genetic information in real time and, for example, alerts the physician if a medication is unlikely to be effective or will cause side effects. ActX can also warn the physician about serious, actionable medical risks. For more information about ActX and taking the next step towards precision medicine, visit us at http://www.actx.com, contact us at info(at)actx.com or call 888-998-2289.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Joe Sichel
ActX
+1 (888) 998-2289 Ext: 101
Email >
ActX, Inc.

Visit website